Range Advisory, LLC’s Merck MRK Stock Holding History

Range Advisory, LLC’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$829K	Buy	6,452 +1,539	+31%	+$180K	0.1%	110
2026 Q1	$591K	Buy	4,913 +1,839	+60%	+$212K	0.11%	107
2025 Q4	$324K	Buy	+3,074	New	+$289K	0.08%	138

Other funds holding MRK

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Range Advisory, LLC's MRK Position: Q2 2026 in Review

Range Advisory, LLC increased its Merck (MRK) stake by 31% in Q2 2026, buying an estimated $180K and bringing the position to 6,452 shares worth $829K. The position accounts for 0.1% of the portfolio, ranked #110.

Range Advisory, LLC first reported a position in MRK in Q4 2025 and has held it in 3 quarters since. 3,833 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

Range Advisory, LLC held 6,452 shares of Merck worth $829K as of Q2 2026.
Range Advisory, LLC bought 1,539 Merck shares in Q2 2026, an estimated $180K.
Merck made up 0.1% of Range Advisory, LLC's portfolio in Q2 2026, its #110 holding.
Range Advisory, LLC first reported a position in Merck in Q4 2025 and has held it in 3 quarters since.
3,833 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Range Advisory, LLC's 13F filing for Q2 2026, filed 2 Sep 2026.